Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
Spero Therapeutics, Inc.Listing on record | Sell | $12.9K | SEC | |
Spero Therapeutics, Inc.Listing on record | Award | — | SEC | |
Spero Therapeutics, Inc.Listing on record | Sell | $10.9K | SEC | |
Spero Therapeutics, Inc.Listing on record | Sell | $43.1K | SEC | |
Spero Therapeutics, Inc.Listing on record | Sell | $8K | SEC | |
Spero Therapeutics, Inc.Listing on record | Award | — | SEC | |
Spero Therapeutics, Inc.Listing on record | Sell | $87.4K | SEC | |
Spero Therapeutics, Inc.Listing on record | Award | — | SEC | |
Spero Therapeutics, Inc.Listing on record | Sell | $11.4K | SEC | |
Spero Therapeutics, Inc.Listing on record | Sell | $22.2K | SEC | |
Spero Therapeutics, Inc.Listing on record | Award | — | SEC | |
Spero Therapeutics, Inc.Listing on record | Award | — | SEC | |
Spero Therapeutics, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Spero Therapeutics, Inc.Listing on record | Sell | $116.6K | SEC | |
Spero Therapeutics, Inc.Listing on record | ExerciseD (derivative) | — | SEC | |
Spero Therapeutics, Inc.Listing on record | Exercise | $47.2K | SEC | |
Spero Therapeutics, Inc.Listing on record | Award | — | SEC | |
Spero Therapeutics, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Spero Therapeutics, Inc.Listing on record | Exercise | $12.6K | SEC | |
Spero Therapeutics, Inc.Listing on record | Sell | $30.5K | SEC | |
Spero Therapeutics, Inc.Listing on record | Exercise | $43.5K | SEC | |
Spero Therapeutics, Inc.Listing on record | ExerciseD (derivative) | — | SEC | |
Spero Therapeutics, Inc.Listing on record | ExerciseD (derivative) | — | SEC | |
Spero Therapeutics, Inc.Listing on record | Sell | $106.3K | SEC | |
Spero Therapeutics, Inc.Listing on record | Sell | $285 | SEC |